XML 21 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows Statement - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income (loss) including noncontrolling interests in operating subsidiaries $ 131,984,000 $ (43,922,000)
Adjustments to reconcile net loss including noncontrolling interests in operating subsidiaries to net cash provided by operating activities:    
Gain on Conversion of Loan and Accrued Interest (2,671,000) 0
Gain on exercise of warrant 4,616,000 0
Change in fair value of investment, net (146,281,000) 0
Depreciation and amortization 16,780,000 28,105,000
Non-cash stock compensation 13,068,000 5,754,000
Impairment of Intangible Assets (Excluding Goodwill) 2,248,000 40,165,000
Other (473,000) (81,000)
Changes in assets and liabilities:    
Restricted cash 11,512,000 (3,316,000)
Accounts receivable 26,450,000 (20,200,000)
Prepaid expenses and other assets (874,000) 1,191,000
Accounts payable and accrued expenses (6,608,000) 5,392,000
Royalties and contingent legal fees payable 5,916,000 10,131,000
Net cash provided by operating activities 46,435,000 23,219,000
Cash flows from investing activities:    
Payments to Acquire Other Investments (31,514,000) 0
Advances to Investee (4,000,000) (10,000,000)
Purchase of available-for-sale investments (424,945,000) (62,633,000)
Maturities and sale of available-for-sale investments 386,920,000 32,352,000
Patent portfolio investment costs 0 (1,000,000)
Purchases of property and equipment 0 (4,000)
Net cash provided by (used in) investing activities (73,539,000) (41,285,000)
Cash flows from financing activities:    
Repurchased Restricted Common Stock 35,000 25,000
Payments to Noncontrolling Interests 0 1,358,000
Proceeds from exercises of stock options 680,000 242,000
Net cash used in financing activities 645,000 (1,141,000)
Increase (decrease) in cash and cash equivalents (26,459,000) (19,207,000)
Cash and cash equivalents, beginning 127,540,000 135,223,000
Cash and cash equivalents, ending 101,081,000 116,016,000
Other Noncash Income (Expense) $ 23,061,000 $ 0